Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) is now available.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhongxin Pharmaceutical Group Corporation Limited, held its first extraordinary general meeting for the financial year 2025. The meeting took place on June 9, 2025, at the Da Ren Tang Mansion in Tianjin, China, and was simultaneously available via video conferencing for shareholders in Singapore. The meeting was chaired by Ms. Wang Lei, and voting was conducted both on-site and online for A-Share Shareholders.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Learn more about 2TZ stock on TipRanks’ Stock Analysis page.